Search Results - "Chandika, Vitya"
-
1
The Association between Anemia and Mortality of Severe Pneumonia COVID-19 Patients in the High Care Unit of a Tertiary Hospital in Jakarta
Published in Acta medica Indonesiana (01-01-2024)“…Numerous studies explored the association between anemia and mortality in patients with severe pneumonia due to COVID-19. However, the findings were…”
Get full text
Journal Article -
2
The Role of Brentuximab Vedotin in the Era of Pandemic COVID-19
Published in International medical case reports journal (30-06-2022)“…Background: Salvage conventional chemotherapy followed by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) is the treatment of choice…”
Get full text
Journal Article -
3
The Role of Brentuximab Vedotin
Published in International medical case reports journal (30-06-2022)“…Background: Salvage conventional chemotherapy followed by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) is the treatment of choice…”
Get full text
Journal Article -
4
The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
Published in International medical case reports journal (01-06-2022)“…Salvage conventional chemotherapy followed by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) is the treatment of choice for most…”
Get full text
Journal Article -
5
Unilateral Tonsillar Swelling as a Manifestation of Diffuse Large B Cell Lymphoma (DLBCL): Case Report
Published in Mædica (15-12-2021)“…Approximately 30-40% of all diffuse large B-cell lymphoma (DLBCL) cases, which have initially been present in extranodal sites with the most common…”
Get full text
Journal Article -
6
Unilateral Tonsillar Swelling as a Manifestation of Diffuse Large B Cell Lymphoma (DLBCL): Case Report
Published in Mædica (01-12-2021)“…Approximately 30-40% of all diffuse large B-cell lymphoma (DLBCL) cases, which have initially been present in extranodal sites with the most common…”
Get full text
Journal Article -
7
The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
Published in International medical case reports journal (01-01-2022)“…BackgroundSalvage conventional chemotherapy followed by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) is the treatment of choice for…”
Get full text
Report